Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-09-22

Clinical Trial Update: Mean Percentage of Levothyroxine Dosage Increase in Patients With Hypothyroidism Started on Enteral Feeding [Phase 4]

View source ↗

Summary

Phase 4 trial investigating changes in levothyroxine dosage for hypothyroidism patients started on enteral feeding was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levothyroxine (levothyroxine)

Snippet

Sponsor: Jocelyne Karam | Conditions: Hypothyroidism | Phase 4 | Status: WITHDRAWN